Charles Grassley news from FierceHealthcare
News
Non-profit hospital tax breaks attacked by Grassley, again
Well, folks, if you thought Sen. Chuck Grassley (R-Iowa) was ready to take a breather on the subject of non-profit hospital tax breaks, think again. This week, the Senator used a hearing on Read more...
Drug companies plan to disclose grant funding
Hoping to stave off outside regulation by Congress, a group of the nation's largest drug and device manufacturers have put forth plans to publicly disclose the grants they make to outside Read more...
Congress says drugmakers held back Vytorin data
Cholesterol drug Vytorin--and makers Merck and Schering-Plough--have been under fire for months since a study suggested that the expensive combo med works no better than much less costly Zocor. Read more...
GAO to study FDA's post-approval review process
Prompted by calls from Sen. Charles Grassley, the Government Accountability office has set plans to review the current method by which the FDA approves some drugs, including challenged medications Read more...
Ohio AG working to define charity care
Ohio Attorney General Marc Dann has kicked off an initiative under which he plans to better define what the state's not-for-profit hospitals must do to keep their state property tax exemption. Among Read more...
MD leaked Avandia results to GSK
A physician with a previous financial relationship with GlaxoSmithKline has apparently admitted that he leaked a study critical of Avandia's safety to drugmaker GlaxoSmithKline two weeks before it Read more...
Feds to crank up non-profit charity demands
Watch out, charity hospitals--Sen. Chuck Grassley is coming after you. In recent times, the Iowa Senator has been on the warpath over what he considers to be inadequate levels of charity care Read more...
AHA makes headway on community-benefit reporting
The American Hospital Association has won broad support from the U.S. House of Representatives in its attempt to change the IRS's proposed community-benefit reporting rules. More than 300 members of Read more...
Congress to investigate investor-owned nursing homes
As we reported yesterday in FierceHealthcare, giant investment firm The Carlyle Group is Read more...
Medtronic faces more kickback accusations
Despite having spent $40 million to settle kickback charges, medical device maker Medtronic has continued to pay millions in consulting fees to spine surgeons, according to a whistle-blower involved Read more...
Get more Charles Grassley coverage at:
Paid Research Reports
- Stakeholder Opinions: Percutaneous Coronary Intervention - Adverse events with drug-eluting stents demand a new safety standard
- Impact of Pharmacogenomics on Public Healthcare Policy
- The Cardiovascular Disorders Market Outlook to 2012
- 2008 Trends to Watch: Pharmaceutical Technology
- Pharmaceutical Pricing and Reimbursement: Strategies for market access across the US, Europe, Japan and other key geographies




